SNDL (SNDL) investor relations material

Executive summary

• Net revenue for Q2 2026 was $235.8M, down 3.7% year-over-year due to persistent demand softness and market headwinds in both liquor and cannabis segments.

• Gross profit declined 16.6% to $56.3M, with gross margin falling to 23.9%, down 3.7 percentage points year-over-year.

• Free cash flow improved to $(6.7)M, a $1.2M year-over-year improvement, despite seasonal payments and increased cash in transit.

• Operating loss was $7.8M; adjusted operating loss was $7.0M, reflecting production ramp-up costs and margin declines.

• Strategic milestones included accelerated share repurchases, completion of the Parallel restructuring, and profit enhancement initiatives targeting over $20M incremental operating income for the remainder of 2026.

Financial highlights

• Q2 2026 net revenue: $235.8M, down 3.7% year-over-year.

• Gross profit: $56.3M, down $11.3M year-over-year.

• Gross margin: 23.9%, down 3.7 percentage points.

• Adjusted operating loss: $7.0M; operating loss: $7.8M.

• Free cash flow: $(6.7)M, improved by 15.2% year-over-year.

Outlook and guidance

• Focus remains on driving sustained profitability, free cash flow growth, and operational efficiency.

• Liquor Retail and Cannabis Retail expected to see margin and free cash flow accretion in the second half.

• Management expects stronger performance in the second half of 2026 and positive free cash flow for the full year.

• Parallel restructuring expected to provide direct U.S. medical cannabis exposure and potential for over $1B in annual revenue.

• Profit enhancement initiatives are expected to drive over $20M in incremental operating income, mostly in the second half of 2026.